3404 related articles for article (PubMed ID: 26132597)
61. Interventions for bacterial folliculitis and boils (furuncles and carbuncles).
Lin HS; Lin PT; Tsai YS; Wang SH; Chi CC
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013099. PubMed ID: 33634465
[TBL] [Abstract][Full Text] [Related]
62. Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis.
El-Batawy MM; Bosseila MA; Mashaly HM; Hafez VS
J Dermatol Sci; 2009 May; 54(2):76-87. PubMed ID: 19303745
[TBL] [Abstract][Full Text] [Related]
63. How Clinically Relevant Are Treatment Comparisons of Topical Calcineurin Inhibitor Trials for Atopic Eczema?
Wilkes SR; Nankervis H; Tavernier E; Maruani A; Williams HC
J Invest Dermatol; 2016 Oct; 136(10):1944-1949. PubMed ID: 27265005
[TBL] [Abstract][Full Text] [Related]
64. Topical use of pimecrolimus in atopic dermatitis: update on the safety and efficacy.
Werfel T
J Dtsch Dermatol Ges; 2009 Sep; 7(9):739-42. PubMed ID: 19650820
[TBL] [Abstract][Full Text] [Related]
65. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.
Wellington K; Jarvis B
Drugs; 2002; 62(5):817-40. PubMed ID: 11929333
[TBL] [Abstract][Full Text] [Related]
66. Recommendations for pimecrolimus 1% cream in the treatment of mild-to-moderate atopic dermatitis: from medical needs to a new treatment algorithm.
Luger T; De Raeve L; Gelmetti C; Kakourou T; Katsarou A; Lambert J; Morren MA; Oranje A; Ruer M; Serdaroglu S; Torrelo A; Werfel T
Eur J Dermatol; 2013; 23(6):758-66. PubMed ID: 24185493
[TBL] [Abstract][Full Text] [Related]
67. Short-term efficacy and safety of biologics and Janus kinase inhibitors for patients with atopic dermatitis: A systematic review and meta-analysis.
Chen Q; Cui L; Hu Y; Chen Z; Gao Y; Shi Y
Heliyon; 2023 Nov; 9(11):e22014. PubMed ID: 38034798
[TBL] [Abstract][Full Text] [Related]
68. Topical antibiotics for preventing surgical site infection in wounds healing by primary intention.
Heal CF; Banks JL; Lepper PD; Kontopantelis E; van Driel ML
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011426. PubMed ID: 27819748
[TBL] [Abstract][Full Text] [Related]
69. Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema.
Prucha H; Schnopp C; Akdis C; Lauener R; Wollenberg A; Ring J; Traidl-Hoffmann C
Expert Opin Drug Metab Toxicol; 2013 Nov; 9(11):1507-16. PubMed ID: 23876065
[TBL] [Abstract][Full Text] [Related]
70. A multicenter trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic dermatitis in Korea.
Won CH; Seo PG; Park YM; Yang JM; Lee KH; Sung KJ; Park CW; Kim DW; Chang HS; Won YH; Kim KH
J Dermatolog Treat; 2004 Jan; 15(1):30-4. PubMed ID: 14754647
[TBL] [Abstract][Full Text] [Related]
71. Meta-analysis on the comparison between two topical calcineurin inhibitors in atopic dermatitis.
Yin ZQ; Zhang WM; Song GX; Luo D
J Dermatol; 2012 Jun; 39(6):520-6. PubMed ID: 22409418
[TBL] [Abstract][Full Text] [Related]
72. Interventions for pityriasis rosea.
Contreras-Ruiz J; Peternel S; Jiménez Gutiérrez C; Culav-Koscak I; Reveiz L; Silbermann-Reynoso ML
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684696
[TBL] [Abstract][Full Text] [Related]
73. Interventions for prevention of herpes simplex labialis (cold sores on the lips).
Chi CC; Wang SH; Delamere FM; Wojnarowska F; Peters MC; Kanjirath PP
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010095. PubMed ID: 26252373
[TBL] [Abstract][Full Text] [Related]
74. Interventions for chronic pruritus of unknown origin.
Andrade A; Kuah CY; Martin-Lopez JE; Chua S; Shpadaruk V; Sanclemente G; Franco JV
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013128. PubMed ID: 31981369
[TBL] [Abstract][Full Text] [Related]
75. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.
Cheer SM; Plosker GL
Am J Clin Dermatol; 2001; 2(6):389-406. PubMed ID: 11770393
[TBL] [Abstract][Full Text] [Related]
76. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
Hultsch T; Kapp A; Spergel J
Dermatology; 2005; 211(2):174-87. PubMed ID: 16088174
[TBL] [Abstract][Full Text] [Related]
77. Interventions for cutaneous disease in systemic lupus erythematosus.
Hannon CW; McCourt C; Lima HC; Chen S; Bennett C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007478. PubMed ID: 33687069
[TBL] [Abstract][Full Text] [Related]
78. Interventions for cutaneous molluscum contagiosum.
van der Wouden JC; van der Sande R; Kruithof EJ; Sollie A; van Suijlekom-Smit LW; Koning S
Cochrane Database Syst Rev; 2017 May; 5(5):CD004767. PubMed ID: 28513067
[TBL] [Abstract][Full Text] [Related]
79. Safety, efficacy, and dosage of 1% pimecrolimus cream for the treatment of atopic dermatitis in daily practice.
Lübbe J; Friedlander SF; Cribier B; Morren MA; García-Díez A; Gelmetti C; Hofmann H; Houwing RH; Kownacki S; Langley RG; Virtanen M; Wolff K; Wisseh S; McGeown C; Abrams B; Schneider D;
Am J Clin Dermatol; 2006; 7(2):121-31. PubMed ID: 16605292
[TBL] [Abstract][Full Text] [Related]
80. Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis: review of randomised, double-blind clinical studies conducted in Japan.
Nakagawa H
Clin Drug Investig; 2006; 26(5):235-46. PubMed ID: 17163257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
